GlassScriptPhysician profile
Brian R Cabarrus
NPI 1598807265
$10,316.85
in general payments reported to CMS, 2019-2025
32 companies · $1,626 in 2025
The $1,626 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,475 · 2020: $588 · 2021: $511 · 2022: $1,593 · 2023: $1,890 · 2024: $2,634 · 2025: $1,626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,648 · Travel and Lodging: $973 · Consulting Fee: $530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,647.76 |
| Travel and Lodging | $972.84 |
| Consulting Fee | $530.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,220.32 | 2019-2025 | Watchman Flx, Watchman Access System, Rotablator Rotational Atherectomy System Console Kit |
| Edwards Lifesciences Corporation | $1,350.65 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $1,300.50 | 2023-2025 | Navitor, Mitraclip, Xience Skypoint |
| E.R. Squibb & Sons, L.L.C. | $602.04 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $537.65 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $475.13 | 2019-2024 | Brilinta |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $391.62 | 2019-2025 | Lifevest |
| Irhythm Technologies, INC. | $343.82 | 2022-2024 | Zio Xt Patch |
| Janssen Pharmaceuticals, INC | $276.35 | 2019-2024 | Xarelto |
| Medtronic, INC. | $265.20 | 2022-2025 | Corevalve Evolut R |
| Cvrx, INC. | $227.79 | 2022-2023 | Barostim Neo System |
| Terumo Medical Corporation | $169.64 | 2024-2025 | Metacross Otw, Angio-Seal, Glidewire |
| Shockwave Medical, INC | $165.87 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $156.21 | 2019-2024 | |
| Ge Healthcare | $148.35 | 2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $116.19 | 2019-2025 | |
| Medtronic Vascular, INC. | $115.35 | 2019 | |
| Sanofi-Aventis U.S. LLC | $109.63 | 2019-2024 | |
| Baxter Healthcare | $56.57 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Amarin Pharma, INC. | $49.10 | 2020-2022 | |
| Astellas Pharma US INC | $38.95 | 2019-2020 | |
| Scpharmaceuticals INC. | $30.61 | 2023 | |
| Arbor Pharmaceuticals, INC. | $25.45 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $24.81 | 2024 | Arcalyst |
| United Therapeutics Corporation | $17.16 | 2019 | |
| Philips North America LLC | $16.95 | 2022 | |
| Novo Nordisk INC | $16.02 | 2023 | Ozempic, Rybelsus |
| Regeneron Healthcare Solutions, INC. | $14.87 | 2023 | Evkeeza |
| Stryker Corporation | $14.84 | 2025 | Clottriever Bold Catheter |
| Chiesi USA, INC. | $14.10 | 2022 | |
| Lundbeck LLC | $12.96 | 2020 | |
| Teleflex LLC | $12.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Cabarrus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.